Evidence map›Paper›PMID 36940598›Full record

Trial reportDrug and alcohol dependence2023

Cognitive behavioral therapy for insomnia to reduce cannabis use: Results from a pilot randomized controlled trial.

J Todd Arnedt, Deirdre A Conroy, Haylie Stewart, Emily Yeagley, Gabrielle Bowyer, Kipling M Bohnert, Mark A Ilgen

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Daily-level associations between sleep hygiene, cannabis use, and sleep health outcomes.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026
    Article
  4. What sleep physicians need to know about cannabis use for sleep.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

J Todd ArnedtSleep and Circadian Research Laboratory, Department of Psychiatry, Michigan Medicine, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA. Electronic address: tarnedt@med.umich.edu.
Deirdre A ConroySleep and Circadian Research Laboratory, Department of Psychiatry, Michigan Medicine, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA.
Haylie StewartThe Addiction Center, Department of Psychiatry, Michigan Medicine, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA.
Emily YeagleyThe Addiction Center, Department of Psychiatry, Michigan Medicine, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA; Center for Clinical Management Research, Ann Arbor VA Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA.
Gabrielle BowyerThe Addiction Center, Department of Psychiatry, Michigan Medicine, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA.
Kipling M BohnertDepartment of Epidemiology and Biostatistics, Michigan State University, 909 Wilson Road Room B601, East Lansing, MI 48824, USA.
Mark A IlgenThe Addiction Center, Department of Psychiatry, Michigan Medicine, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA; Center for Clinical Management Research, Ann Arbor VA Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA.
Michigan Medicine · USVA Ann Arbor Healthcare System · USMichigan State University · US

Funding

Reducing cannabis use for sleep among adults using medical cannabisR34DA047466 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARNEDT, J. TODD, ILGEN, MARK A. · 2018 to 2020
$702k
Dual Diagnosis Inpatients: Telephone Monitoring RCT to Improve OutcomesI01HX000109 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI ILGEN, MARK A., TIMKO, CHRISTINE D · 2011 to 2015
–
HSR&D Research Career Scientist AwardIK6HX002841 · VA · VETERANS HEALTH ADMINISTRATION · PI MARK A. ILGEN · 2020 to 2026
–
HSRD VA I01 HX000109HSRD VA IK6 HX002841NIDA NIH HHS R34 DA047466
6 · The paper itself

Abstract

backgroundIndividuals with regular cannabis use demonstrate adverse health outcomes, yet infrequently seek treatment. Insomnia, a common co-occurring complaint, could be targeted to reduce cannabis use and improve functioning in these individuals. In an intervention development study, we refined and tested the preliminary efficacy of a telemedicine-delivered CBT for insomnia tailored to individuals with regular cannabis use for sleep (CBTi-CB-TM).

methodsIn this single-blind randomized trial, fifty-seven adults (43 women, mean age 37.6 ± 12.8 years) with chronic insomnia and cannabis use for sleep ≥3 times/week received CBTi-CB-TM (n = 30) or sleep hygiene education (SHE-TM, n = 27). Participants completed self-reported assessments of insomnia (Insomnia Severity Index [ISI]) and cannabis use (Timeline Followback [TLFB] and daily diary data) at pre-treatment, post-treatment, and 8-week follow-up.

resultsISI scores improved significantly more in the CBTi-CB-TM compared to SHE-TM condition (β = -2.83, se=0.84, P = 0.004, d=0.81). At 8-week follow-up, 18/30 (60.0 %) CBTi-CB-TM compared to 4/27 (14.8 %) SHE-TM participants were in remission from insomnia (X

conclusionsCBTi-CB-TM is feasible, acceptable, and demonstrated preliminary efficacy for improving sleep and cannabis-related outcomes among non-treatment-seeking individuals with regular cannabis use for sleep. Although sample characteristics limit generalizability, these findings support the need for adequately powered randomized controlled trials with longer follow-up periods.

Indexed as

CannabisCognitive Behavioral TherapySleep Initiation and Maintenance DisordersAdultFemaleHumansMiddle AgedPilot ProjectsSingle-Blind MethodTreatment OutcomeYoung AdultCannabisCBTInsomniaRandomized controlled trialTelemedicine

Identifiers

PMID36940598
PMCPMC12922515
OpenAlexW4323929161

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.